| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15,950 |
12,024 |
$555K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,252 |
5,856 |
$396K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,008 |
5,673 |
$285K |
| 99000 |
|
4,695 |
3,734 |
$101K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,847 |
1,541 |
$91K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,376 |
1,027 |
$69K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,242 |
2,359 |
$40K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
933 |
696 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
520 |
217 |
$12K |
| 86769 |
|
101 |
51 |
$4K |
| 86328 |
|
51 |
47 |
$2K |
| 99072 |
|
1,682 |
1,130 |
$2K |
| 0002A |
|
43 |
40 |
$2K |
| 0011A |
|
53 |
51 |
$2K |
| 0003A |
|
29 |
23 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
41 |
29 |
$829.45 |
| 86735 |
|
51 |
36 |
$689.11 |
| 0001A |
|
13 |
13 |
$547.82 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15 |
14 |
$235.50 |
| 91300 |
|
15 |
14 |
$0.00 |
| 91301 |
|
12 |
12 |
$0.00 |